Year-end Sale % OFF 
Abstract
Hypercholesterolaemia has not been part of our clinical vocabulary for several decades, so why has hypertension not gone the same way? The latest individual participant-level data meta-analysis from the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC)1 is yet another nail in the coffin for hypertension. The new study included 51 trials, with 358 707 participants (149 211 [41·6%] women and 209 496 [58·4%] men) aged 21–105 years, who had 42 947 major cardiovascular events during approximately 4 years of follow-up.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
